Thus far, no guidelines for prevention of perinatal transmission have been put forth.
Injectable drug use is the most common route of hepatitis C acquisition — and in the current opioid epidemic, infection rates are escalating. The CDC reports that during 2011–2014, rates of hepatitis C detection in U.S. women of childbearing age (range,15–44) increased 22%, hepatitis C testing of children aged ≤2 years increased 14%, and the proportion of children born to hepatitis C–infected women rose from 0.19% to 0.32%. Vertical transmission of hepatitis C occurs in 5.8% of infants born to infected women.
In Kentucky, a state particularly affected by drug use, rates of hepatitis C detection in women of childbearing age increased 3-fold, and testing of children for hepatitis C increased 2.5-fold. Concurrently, the proportion of infants bo…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)